Cyclical and dose-dependent responses of adult human mature oligodendrocytes to fingolimod

American Journal of Pathology

Volumn 173, Issue 4, 2008, Pages 1143-1152

  Miron, Veronique E ^a   Hall, Jeffery A ^a   Kennedy, Timothy E ^a   Soliven, Betty ^b   Antel, Jack P ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; FINGOLIMOD; GLUCOSE; MESSENGER RNA; MYELIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE; SURAMIN;

APOPTOSIS; ARTICLE; CELL MATURATION; CELL SURVIVAL; CYTOSKELETON; DOSE RESPONSE; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL CULTURE; NERVE CELL MEMBRANE; OLIGODENDROGLIA; PRIORITY JOURNAL; SERUM; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 53149089045     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.080478     Document Type: Article

References (48)

1. Sherman DL, Brophy PJ: Mechanisms of axon ensheathment and myelin growth. Nat Rev Neurosci 2005, 6:683-690
2. Smith ME: The turnover of myelin in the adult rat. Biochim Biophys Acta 1968, 164:285-293
3. Agrawal HC, Trotter JL, Burton RM, Mitchell RF: Metabolic studies on myelin. Evidence for a precursor role of a myelin subfraction. Biochem J 1974, 140:99-109
4. Lajtha A, Toth J, Fujimoto K, Agrawal HC: Turnover of myelin proteins in mouse brain in vivo. Biochem J 1977, 164:323-329
5. Lassmann H, Bruck W, Lucchinetti CF: The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007, 17:210-218
6. Sanchez T, Hla T: Structural and functional characteristics of S1P receptors. J Cell Biochem 2004, 92:913-922
7. Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW: Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006, 355:1124-1140
8. Billich A, Bornancin F, Devay P, Mechtcheriakova D, Urtx N, Baumruker T: Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J Biol Chem 2003, 278:47408-47415
9. Foster CA, Howard LM, Schweitzer A, Persohn E, Hiestand PC, Belatoni B, Reuschel R, Beerli C, Schwartz M, Billich A: Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis. J Pharmacol Exp Ther 2007, 323:469-475
10. Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP: FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol 2008, 63:61-71
11. Jung CG, Kim HJ, Miron VE, Cook S, Kennedy TE, Foster CA, Antel JP, Soliven B: Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia 2007, 55:1656-1667
12. Coelho RP, Payne SG, Bittman R, Spiegel S, Sato-Bigbee C: The immunomodulator FTY720 has a direct cytoprotective effect in oligodendrocyte progenitors. J Pharmacol Exp Ther 2007, 323:626-635
13. Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 2002, 296:346-349
14. Davis MD, Clemens JJ, Macdonald TL, Lynch KR: Sphingosine 1-phosphate analogs as receptor antagonists. J Biol Chem 2005, 280:9833-9841
15. Beer MS, Stanton JA, Salim K, Rigby M, Heavens RP, Smith D, Mcallister G: EDG receptors as a therapeutic target in the nervous system. Ann NY Acad Sci 2000, 905:118-131
16. Liu CH, Thangada S, Lee MJ, Van Brocklyn JR, Spiegel S, Hla T: Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1. Mol Biol Cell 1999, 10:1179-1190
17. Goetzl EJ, Rosen H: Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 2004, 114:1531-1537
18. Sawicka E, Dubois G, Jarai G, Edwards M, Thomas M, Nicholls A, Albert R, Newson C, Brinkmann V, Walker C: The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity. J Immunol 2005, 175:7973-7980
19. Webb M, Tham CS, Lin FF, Lariosa-Willingham K, Yu N, Hale J, Mandala S, Chun J, Rao TS: Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice. J Neuroimmunol 2004, 153:108-121
20. Kataoka H, Ohtsuki M, Shimano K, Mochizuki S, Oshita K, Murata M, Sugahara K, Sato N, Hoshino Y, Chiba K: Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: II. Effect of FTY720 and FTY720-phosphate on host-versus-graft and graft-versus-host reaction in mice. Transplant Proc 2005, 37:107-109
21. Terai K, Soga T, Takahashi M, Kamohara M, Ohno K, Yatsugi S, Okada M, Yamaguchi T: Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS. Neuroscience 2003, 116:1053-1062
22. Yu N, Lariosa-Willingham KD, Lin FF, Webb M, Rao TS: Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes. Glia 2004, 45:17-27
23. Toman RE, Payne SG, Watterson KR, Maceyka M, Lee NH, Milstien S, Bigbee JW, Spiegel S: Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension. J Cell Biol 2004, 166:381-392
24. Jaillard C, Harrison S, Stankoff B, Aigrot MS, Calver AR, Duddy G, Walsh FS, Pangalos MN, Arimura N, Kaibuchi K, Zalc B, Lubetzki C: Edg8/S1P5: an oligodendroglial receptor with dual function on process retraction and cell survival. J Neurosci 2005, 25:1459-1469
25. Simons M, Trotter J: Wrapping it up: the cell biology of myelination. Curr Opin Neurobiol 2007, 17:533-540
26. Sloane JA, Vartanian TK: WAVE1 and regulation of actin nucleation in myelination. Neuroscientist 2007, 13:486-491
27. Gardell SE, Dubin AE, Chun J: Emerging medicinal roles for lysophospholipid signaling. Trends Mol Med 2006, 12:65-75
28. Franklin RJ: Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002, 3:705-714
29. Gensert JM, Goldman JE: Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 1997, 19:197-203
30. Kim SU, Moretto G, Ruff B, Shin DH: Culture and cryopreservation of adult human oligodendrocytes and astrocytes. Acta Neuropathol 1984, 64:172-175
31. Gräler MH, Goetzl EJ: The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G-protein-coupled receptors. FASEB J 2004, 18:551-553
32. Lan YY, De Creus A, Colvin BL, Abe M, Brinkmann V, Coates PT, Thomson AW: The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo. Am J Transplant 2005, 5:2649-2659
33. Park SI, Felipe CR, Machado PG, Garcia R, Skerjanec A, Schmouder R, Tedesco-Silva JH, Medina-Pestana JO: Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients. Braz J Med Biol Res 2005, 38:683-694
34. Yong VW, Antel JP: Culture of glia cells from human brain biopsies. Protocols for Neural Cell Culture. Edited by Federoff S, Richardson A. New York, Humana, 2001, pp 81-96
35. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP: Multiple sclerosis: fas signaling in oligodendrocyte cell death. J Exp Med 1996, 184:2361-2370
36. Wosik K, Ruffini F, Almazan G, Olivier A, Nalbantoglu J, Antel JP: Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Brain 2004, 127:2636-2648
37. Miron VE, Rajasekharan S, Jarjour AA, Zamvil SS, Kennedy TE, Antel JP: Simvastatin regulates oligodendroglial process dynamics and survival. Glia 2007, 55:130-143
38. Dawson J, Hotchin N, Lax S, Rumsby M: Lysophosphatidic acid induces process retraction in CG-4 line oligodendrocytes and oligodendrocyte precursor cells but not in differentiated oligodendrocytes. J Neurochem 2003, 87:947-957
39. Graeler M, Shankar G, Goetzl EJ: Cutting edge: suppression of T cell chemotaxis by sphingosine 1-phosphate. J Immunol 2002, 169:4084-4087
40. Jin Y, Knudsen E, Wang L, Bryceson Y, Damaj B, Gessani S, Maghazachi AA: Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood 2003, 101:4909-4915
41. Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, McCrea E, Shapiro A, Antel JP: TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 2005, 175:4320-4330
42. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG: Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004, 427:355-360
43. Ancellin N, Hla T: Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 1999, 274:18997-19002
44. Niedernberg A, Blaukat A, Schoneberg T, Kostenis E: Regulated and constitutive activation of specific signalling pathways by the human S1P5 receptor. Br J Pharmacol 2003, 138:481-493
45. Alabed YZ, Grados-Munro E, Ferraro GB, Hsieh SH, Fournier AE: Neuronal responses to myelin are mediated by rho kinase. J Neurochem 2006, 96:1616-1625
46. Lee CW, Rivera R, Dubin AE, Chun J: LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation. J Biol Chem 2007, 282:4310-4317
47. Niedernberg A, Scherer CR, Busch AE, Kostenis E: Comparative analysis of human and rat S1P(5) (edg8): differential expression profiles and sensitivities to antagonists. Biochem Pharmacol 2002, 64:1243-1250
48. Novgorodov AS, El Alwani M, Bielawski J, Obeid LM, Gudz TI: Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration. FASEB J 2007, 21:1503-1514